ICD-10-CM Billable Code

T38.99

Poisoning by, adverse effect of and underdosing of other hormone antagonists

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code T38.99 pertains to cases of poisoning, adverse effects, or underdosing related to hormone antagonists not categorized elsewhere. Hormone antagonists are medications used to inhibit the effects of certain hormones, often in the treatment of cancers, hormonal imbalances, or endocrine disorders. While these drugs are vital in managing various health conditions, improper use or accidental poisoning can lead to serious health complications. Recognizing the risks and understanding the potential signs of adverse reactions are important for ensuring safe medication management.

Causes & Symptoms

Clinical Causes: Accidental ingestion of hormone antagonist medication by children or others Overdose due to intentional misuse or abuse of the medication Incorrect dosage prescribed or administered by healthcare providers Sensitivity or allergic reactions resulting from the medication Drug interactions leading to enhanced or adverse effects Failure to follow prescribed instructions during hormone antagonist therapy

Key Symptoms: Nausea and vomiting Abdominal pain or discomfort Dizziness or weakness Allergic reactions such as rash, itching, or swelling Changes in blood pressure, either high or low Breathing difficulties in severe cases Altered mental status or confusion Signs of hormonal imbalance such as breast tenderness or menstrual irregularities Potential liver or kidney dysfunction in prolonged or severe cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis of poisoning or adverse effects related to hormone antagonists involves a comprehensive medical evaluation. Healthcare providers may perform blood tests to determine medication levels and assess organ function. Additional diagnostic procedures might include urine analysis and imaging studies if complications like organ damage are suspected. It is important to identify the specific hormone antagonist involved to tailor appropriate management strategies.

Treatment Protocols: Treatment strategies focus on stabilizing the patient and preventing further absorption of the medication. Immediate steps may include administering activated charcoal if ingestion was recent, providing supportive care such as IV fluids, and monitoring vital signs. In some cases, specific antidotes or reversal agents may be administered if available. Hospital admission may be necessary for severe cases to manage complications and ensure recovery. Long-term management involves adjusting medication regimens and educating patients about safe medication use to prevent recurrence.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T38.99 a billable ICD-10 code?
Yes, T38.99 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T38.99?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of other hormone antagonists and any associated comorbidities for accurate reporting.

Cite this Clinical Reference